Manchester, UK – DeepMed IO Ltd announced today that its quality management system (QMS) has been successfully certified as per ISO 13485:2016 requirements by HTCert Notified Body (2803) with scope “Design, development, production, technical assistance and installation of medical device software for precision medicine and digital/computational pathology”. DeepMed IO Ltd ISO 13485:2016 certification serves to [...]
We are excited to announce our new technical partnership with Inspirata! DeepPath™ LYDIA, DeepMed IO's AI-powered Metastasis Detection Technology can now be integrated into Inspirata's Dynamyx™ through its open API. Dynamyx™ streamlines case management, facilitates communication and accelerates pathology workflows, while DeepPath™ LYDIA uses AI to offer decision support for faster and more accurate staging as [...]
We are extremely exited because on November 27, 2019 our team made its 3rd submission to the #camelyon17 Grand Challenge achieving a k of 90.52%!
We are extremely exited because on November 27, 2019 our team made its 3rd submission to the #camelyon17 Grand Challenge achieving a k of 90.52%! This makes our solution the 5th best submitted one in the world among 62 teams and 98 submissions. It must be mentioned that there are only 3 companies present including DeepMed [...]
As part of the Nvidia Inception Program, the UK start-up has used AI to help pathologists classify and detect breast cancer in tissue samples Artificial intelligence and machine learning are being used increasingly in the healthcare industry to make life easier for doctors and improve patient outcomes (Credit: Pixabay) One of the biggest challenges for any [...]
Dr. Konstantinos Vougas from DeepMed IO attended the #symposium of #computational #pathology of the European #pathology Conference at Nice. It was a great experience watching all the high-quality engaging talks and a great honor meeting key influencers in the field like Dina Tiniakos(Professor of Pathology at National & Kapodistrian University of Athens and President of the [...]
15/1/2019: DeepMed IO Ltd secures 150K pounds from the NIHR i4i-connect grant to develop an AI alpha-prototype for standardising breast cancer grading. https://www.nihr.ac.uk/news/nihr-supports-second-wave-of-small-business-medtech-innovations/20354
1/9/2018: DeepMed IO Ltd revceives 1M pounds from the NHS Small Business Research Initiative (SBRI) to develop an AI-powered decision support system for detecting metastases on lymph-nodes from cancer patients. https://sbrihealthcare.co.uk/company/deepmed-io/